Infection Control Market – Global Industry Trends and Forecast to 2024

SUBSCRIBE FOR UPDATED REPORTS

Get great contents delivered straight to your inbox everyday, just a click away, Sign Up Now.
Name
Email
US : +1-888-387-2818
UK : +44 208 089 1725

Global Infection Control Market – Trends and Forecast to 2024

Global
Upcoming Reports
Global Infection Control Market

Global Infection Control Market Product (Disinfection Products {Disinfectants, Medical Nonwovens, Disinfectors, Endoscope Reprocessing Products}, Sterilization Products [Sterilization Equipment {Heat Sterilization, Low Temperature Sterilization}, Radiation Sterilization, Filtration], Consumables and Accessories [Sterilization Indicators, Sterilant Cassettes, Others]}), Services (In-House Sterilization, Control Sterilization Services), End User (Hospitals, Clinics, Medical Device Companies, Food and Beverage Industry, Pharmaceutical Companies, Others), Geography – Industry Trends and Forecast to 2024

Market Analysis: Global Infection Control Market

The global infection control market accounted to USD 15.2 billion in 2016 growing at a CAGR of 6.0% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.Global Infection Control Market

Market Definition: Global Infection Control Market

Infection control is the related to the inhibiting healthcare-associated infection. The process is important for the under documented and under maintained area in the healthcare sector. Infection control and hospital epidemiology are done for the safety of the public health, accomplished within the limitations of a health-care distribution system. Many anti-infective agents are used such as anti-biotics, anti-fungal, anti-bacterial.

Major Market Drivers and Restraints:

  • Increasing Occurrence of Hospital-Acquired Infections
  • Growing Number of Surgical Procedures
  • Concerns Related To The Safety of Instruments
  • Emerging Nations
  • Purification and Sterilization of Advanced Medical Instruments

Market Segmentation: Global Infection Control Market

  • By product the global infection control market is segmented into disinfection products, and sterilization products.
  • Disinfection Products are further sub-segmented into disinfectants, medical nonwovens, disinfectors, and endoscope reprocessing products.
  • On the basis of product type, disinfectants are further sub-segmented into instrument disinfectants, hand disinfectants, surface disinfectants, and skin disinfectants. On the basis of formulation, disinfectants are further sub-segmented into disinfectant liquids, disinfectant wipes, and disinfectant sprays. On the basis of EPA classification, disinfectants are further sub-segmented into low-level disinfectants, high-level disinfectants, and intermediate-level disinfectants.
  • Medical nonwovens are further sub-segmented into surgical drapes, surgical gowns, sterilization wraps, and face masks.
  • Disinfectors are further sub-segmented into washer disinfectors, flusher disinfectors, and UV ray disinfectors.
  • Endoscope reprocessing products are further sub-segmented into automated endoscope reprocessors, endoscope tracking systems, and other endoscope reprocessing products.
  • Sterilization products are further sub-segmented into sterilization equipment and consumables & accessories.
  • Sterilization equipment is further sub-segmented into heat sterilization, low-temperature sterilization, radiation sterilization, and filtration. Heat sterilization is further sub-segmented into moist heat sterilization and dry heat sterilization. Low temperature sterilization is further sub-segmented into ozone gas-based medical sterilization, vaporized hydrogen peroxide (VHP), formaldehyde sterilizers, ethylene oxide sterilization (Eto).
  • Consumables & accessories are further sub-segmented into sterilization indicators, sterilant cassettes, others.
  • On the basis of services the global infection control market is segmented into in-house sterilization and control sterilization services. In-house sterilization is segmented into gamma sterilization, ethylene oxide sterilization, and e-beam sterilization.
  • On the basis of end-user the global infection control market is segmented into hospitals, clinics, medical device companies, food and beverage industry, pharmaceutical companies, and others.
  • On the basis of geography, global infection control market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Competitive Analysis: Global Infection Control Market

The global infection control market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of infection control market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors: Global Infection Control Market

Some of the major players operating in global infection control market are Steris Corporation, Cantel Medical, 3M, Getinge AB, Johnson & Johnson Services Inc., Danaher, Ecolab, WSP, Metall Zug AG, Cantel Medical, Sterigenics International LLC, HYH, MATACHANA GROUP, Dun & Bradstreet, Inc., KCWW, Ahlstrom-Munksjö, Allegion plc., TSO3, BD, Cardinal Health, Ansell and PAUL HARTMANN AG among others

Research Methodology: Global Infection Control Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or drop down your inquiry.

Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Choose Licence Type

Enterprise, Single User

1. INTRODUCTION

       1.1. OVERVIEW OF THE GLOBAL INFECTION CONTROL MARKET
       1.2. MARKET SEGMENTATION & COVERAGE
                     1.2.1. CURRENCY AND PRICING 
                     1.2.2. LIMITATION
                     1.2.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

       2.1. KEY TAKEAWAYS
       2.2. ARRIVING AT THE GLOBAL INFECTION CONTROL MARKET SIZE
                     2.2.1. MARKET CRACKDOWN APPROACH 
                     2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
                     2.2.3. DATA TRIANGULATION
                     2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
                     2.2.5. PRODUCT PIPELINE ANALYSIS
                     2.2.6. PORTER’S FIVE FORCES MATRIX
       2.3. GLOBAL TOPICAL INFECTION CONTROL MARKET: RESEARCH SNAPSHOT
       2.4. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

       4.1. OVERVIEW
       4.2. GLOBAL INFECTION CONTROL MARKET: KEY PRIMARY INSIGHTS
       4.3. MARKET OVERVIEW
                     4.3.1. DRIVERS
                                  4.3.1.1. STRINGENT REGULATIONS IN FOOD SAFETY
                                  4.3.1.2. INCREASED AWARENESS OF HOSPITAL COMMORBIDITY
                                  4.3.1.3. GROWING NUBER OF SURGICAL PROCEDURES
                                  4.3.1.4. RISING INCIDENCE OF ICU ACQUIRED INFECTIONS
                                  4.3.1.5. RISING INCIDENCE OF ICU ACQUIRED INFECTIONS
                                  4.3.1.6. RISING ACCEPTANCE OF HOME HEALTHCARE
                                  4.3.1.7. INCREASED AWARENESS OF INFECTION CONTROL IN ASIA
                     4.3.2. RESTRAINTS
                     4.3.3. OPPURTUNITIES
                     4.3.4. THREATS
       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. EXECUTIVE SUMMARY

6. INFECTION CONTROL MARKET, BY TYPE

       6.1. OVERVIEW
       6.2. DISINFECTION TECHNOLOGY, BY PRODUCT TYPE
                     6.2.1. MEDICAL NONWOVENS, BY PRODUCT TYPE
                                  6.2.1.1. GOWNS
                                  6.2.1.2. DRAPES
                                  6.2.1.3. WRAPS
                                  6.2.1.4. GLOVES
                                  6.2.1.5. MASKS
                                  6.2.1.6. OTHERS
                     6.2.2. DISINFECTANTS
                                  6.2.2.1. DISINFECTANTS, BY APPLICATION
                                                     6.2.2.1.1. HAND
                                                     6.2.2.1.2. SKIN
                                                     6.2.2.1.3. INSTRUMENT
                                                      6.2.2.1.4. SURFACE
                                  6.2.2.2. DISINFECTANTS, BY PRODUCT TYPE
                                                     6.2.2.2.1. WIPES
                                                     6.2.2.2.2. LIQUIDS
                                                     6.2.2.2.3. SPRAYS
                                  6.2.2.3. DISINFECTANTS, BY ENVIRONMENTAL PROTECTION AGENCY (EPA) CLASSIFICATION
                                                     6.2.2.3.1. LOW LEVEL
                                                     6.2.2.3.2. INTERMIDIATE LEVEL
                                                     6.2.2.3.3. HIGH LEVEL
                     6.2.3. DISINFECTORS, BY PRODUCT TYPE
                                  6.2.3.1. WASHER
                                                    6.2.3.1.1. SINGLE CHAMBER
                                                    6.2.3.1.2. MULTI CHAMBER
                                  6.2.3.2. FLUSHER
                                  6.2.3.3. UV RAYS DISINFECTORS
                     6.2.4. ENDOSCOPIC REPROCESSOR
       6.3. STERILIZATION TECHNOLOGY,
                     6.3.1. PRODUCTS, BY METHOD TYPE
                                  6.3.1.1. HEAT STERILIZATION, BY PRODUCT TYPE
                                                    6.3.1.1.1. MOIST HEAT EQUIPMENTS
                                                    6.3.1.1.2. DRY HEAT EQUIPMENTS
                                  6.3.1.2.  LOW TEMPERATURE STERILIZATION, BY PRODUCT TYPE
                                                      6.3.1.2.1.  ETHYLENE OXIDE STERILIZATION (ETO)
                                                      6.3.1.2.2.  VAPORIZED HYDROGEN PEROXIDE (VHP)
                                                      6.3.1.2.3.  HYDROGEN PEROXIDE GAS PLASMA STERILIZATION
                                                      6.3.1.2.4.  OZONE GAS STERILIZATION
                                                      6.3.1.2.5.  FORMALDEHYDE STERILIZATION
                                  6.2.1.3.  RADIATION STERILIZATION
                                  6.2.1.4.  FILTRATION STERILIZATION
                     6.3.2. CONTRACT SERVICES, BY SERVICE TYPE
                                  6.3.2.1.  ETHYLENE OXIDE STERILIZATION SERVICES           
                                  6.3.2.2.  GAMMA STERILIZATION SERVICES 
                                  6.3.2.3.  E-BEAM STERILIZATION SERVICES
                                  6.3.2.4.  OTHERS

7. INFECTION CONTROL MARKET, BY END-USER

       7.1. OVERVIEW
       7.2. HOSPITALS
       7.3. MEDICAL DEVICE MANUFACTURERS
       7.4. PHARMA MANUFACTURERS
       7.5. LABORATORY
       7.6. FOOD AND BEVERAGES
       7.7. OTHERS

8. INFECTION CONTROL MARKET, BY DISTRIBUTION CHANNEL

       8.1. OVERVIEW
       8.2. TENDERS
       8.3. OVER THE COUNTER (OTC)

9. INFECTION CONTROL MARKET, BY GEOGRAPHY

       9.1. COUNTRYWISE INFECTION CONTROL MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
                9.1.1. NORTH AMERICA
                              9.1.1.1.      U.S.
                              9.1.1.2.      CANADA
                              9.1.1.3.      MEXICO
                9.1.2. EUROPE
                              9.1.2.1.      GERMANY
                              9.1.2.2.      FRANCE
                              9.1.2.3.      U.K.
                              9.1.2.4.      ITALY
                              9.1.2.5.      SPAIN
                              9.1.2.6.      RUSSIA
                              9.1.2.7.      TURKEY
                              9.1.2.8.      BELGIUM
                              9.1.2.9.      NETHERLANDS
                              9.1.2.10.      SWITZERLAND
                              9.1.2.11.    REST OF EUROPE
                9.1.3. ASIA-PACIFIC (APAC)
                              9.1.3.1.      JAPAN
                              9.1.3.2.      CHINA
                              9.1.3.3.      SOUTH KOREA
                              9.1.3.4.      INDIA
                              9.1.3.5.      AUSTRALIA
                              9.1.3.6.      SINGAPORE
                              9.1.3.7.      THAILAND
                              9.1.3.8.      MALAYSIA
                              9.1.3.9.      INDONESIA
                              9.1.3.10.      PHILIPPINES
                              9.1.3.11.      REST OF APAC
                9.1.4. LATIN AMERICA
                              9.1.4.1.     BRAZIL
                              9.1.4.2.     REST OF LATIN AMERICA
                9.1.5. MIDDLE EAST AND AFRICA
                              9.1.5.1.     SOUTH AFRICA
                              9.1.5.2.     REST OF MIDDLE EAST AND AFRICA
       9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10. INFECTION CONTROL MARKET: COMPETITIVE LANDSCAPE

       10.1. GLOBAL INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS
       10.2. U.S. INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS
       10.3. EUROPE INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS
       10.4. APAC INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS
       10.5. SOUTH AMERICA INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS
       10.6. MIDDLE EAST AND AFRICA INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS
       10.7. MERGERS & ACQUISITIONS
       10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
       10.9. EXPANSIONS
       10.11. REGULATORY CHANGES
       10.12. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11. INFECTION CONTROL MARKET, COMPANY PROFILES

       11.1. 3M COMPANY
                         11.1.1   COMPANY OVERVIEW
                         11.1.2   SWOT ANALYSIS
                         11.1.3   REVENUE ANALYSIS
                         11.1.4   PRODUCT PORTFOLIO
                         11.1.5   RECENT DEVELOPEMENTS
                         11.1.6   DATA BRIDGE ANALYSIS
       11.2. MMM GROUP
                         11.2.1   COMPANY OVERVIEW
                         11.2.2   SWOT ANALYSIS
                         11.2.3   REVENUE ANALYSIS
                         11.2.4   PRODUCT PORTFOLIO
                         11.2.5   RECENT DEVELOPEMENTS
                         11.2.6   DATA BRIDGE ANALYSIS
       11.3. KIMBERLEY-CLARK
                         11.3.1   COMPANY OVERVIEW
                         11.3.2   SWOT ANALYSIS
                         11.3.3   REVENUE ANALYSIS
                         11.3.4   PRODUCT PORTFOLIO
                         11.3.5   RECENT DEVELOPEMENTS
                         11.3.6   DATA BRIDGE ANALYSIS
       11.4. BELIMED AG (A METALL ZUG GROUP COMPANY)
                         11.4.1   COMPANY OVERVIEW
                         11.4.2   SWOT ANALYSIS
                         11.4.3   REVENUE ANALYSIS
                         11.4.4   PRODUCT PORTFOLIO
                         11.4.5   RECENT DEVELOPEMENTS
                         11.4.6   DATA BRIDGE ANALYSIS
       11.5. CANTEL MEDICAL CORPORATION
                         11.5.1   COMPANY OVERVIEW
                         11.5.2   SWOT ANALYSIS
                         11.5.3   REVENUE ANALYSIS
                         11.5.4   PRODUCT PORTFOLIO
                         11.5.5   RECENT DEVELOPEMENTS
                         11.5.6   DATA BRIDGE ANALYSIS
       11.6. STERIGENICS INTERNATIONAL, INC.
                         11.6.1   COMPANY OVERVIEW
                         11.6.2   SWOT ANALYSIS
                         11.6.3   REVENUE ANALYSIS
                         11.6.4   PRODUCT PORTFOLIO
                         11.6.5   RECENT DEVELOPEMENTS
                         11.6.6   DATA BRIDGE ANALYSIS
       11.7. STERIS PLC
                         11.7.1   COMPANY OVERVIEW
                         11.7.2   SWOT ANALYSIS
                         11.7.3   REVENUE ANALYSIS
                         11.7.4   PRODUCT PORTFOLIO
                         11.7.5   RECENT DEVELOPEMENTS
                         11.7.6   DATA BRIDGE ANALYSIS
       11.8. GETINGE GROUP
                         11.8.1   COMPANY OVERVIEW
                         11.8.2   SWOT ANALYSIS
                         11.8.3   REVENUE ANALYSIS
                         11.8.4   PRODUCT PORTFOLIO
                         11.8.5   RECENT DEVELOPEMENTS
                         11.8.6   DATA BRIDGE ANALYSIS
       11.9. HALYARD HEALTH, INC.
                         11.9.1   COMPANY OVERVIEW
                         11.9.2   SWOT ANALYSIS
                         11.9.3   REVENUE ANALYSIS
                         11.9.4   PRODUCT PORTFOLIO
                         11.9.5   RECENT DEVELOPEMENTS
                         11.9.6   DATA BRIDGE ANALYSIS
       11.10. ADVANCED STERILIZATION PRODUCTS (A JOHNSON & JOHNSON COMPANY)
                         11.9.1   COMPANY OVERVIEW
                         11.9.2   SWOT ANALYSIS
                         11.9.3   REVENUE ANALYSIS
                         11.9.4   PRODUCT PORTFOLIO
                         11.9.5   RECENT DEVELOPEMENTS
                         11.9.6   DATA BRIDGE ANALYSIS
       11.11. MATACHANA GROUP
                         11.11.1   COMPANY OVERVIEW
                         11.11.2   SWOT ANALYSIS
                         11.11.3   REVENUE ANALYSIS
                         11.11.4   PRODUCT PORTFOLIO
                         11.11.5   RECENT DEVELOPEMENTS
                         11.11.6   DATA BRIDGE ANALYSIS
       11.12. OLYMPUS CORPORATION
                         11.12.1   COMPANY OVERVIEW
                         11.12.2   SWOT ANALYSIS
                         11.12.3   REVENUE ANALYSIS
                         11.12.4   PRODUCT PORTFOLIO
                         11.12.5   RECENT DEVELOPEMENTS
                         11.12.6   DATA BRIDGE ANALYSIS
       11.13. DOMTAR CORPORATION
                         11.13.1   COMPANY OVERVIEW
                         11.13.2   SWOT ANALYSIS
                         11.13.3   REVENUE ANALYSIS
                         11.13.4   PRODUCT PORTFOLIO
                         11.13.5   RECENT DEVELOPEMENTS
                         11.13.6   DATA BRIDGE ANALYSIS
       11.14. MEDTRONIC
                         11.14.1   COMPANY OVERVIEW
                         11.14.2   SWOT ANALYSIS
                         11.14.3   REVENUE ANALYSIS
                         11.14.4   PRODUCT PORTFOLIO
                         11.14.5   RECENT DEVELOPEMENTS
                         11.14.6   DATA BRIDGE ANALYSIS
       11.15. BIO-CIDE INTERNATIONAL, INC.
                         11.15.1   COMPANY OVERVIEW
                         11.15.2   SWOT ANALYSIS
                         11.15.3   REVENUE ANALYSIS
                         11.15.4   PRODUCT PORTFOLIO
                         11.15.5   RECENT DEVELOPEMENTS
                         11.15.6   DATA BRIDGE ANALYSIS
       11.16. CAREFUSION CORPORATION
                         11.16.1   COMPANY OVERVIEW
                         11.16.2   SWOT ANALYSIS
                         11.16.3   REVENUE ANALYSIS
                         11.16.4   PRODUCT PORTFOLIO
                         11.16.5   RECENT DEVELOPEMENTS
                         11.16.6   DATA BRIDGE ANALYSIS
       11.17. MOLNLYCKE HEALTH CARE AB
                         11.17.1   COMPANY OVERVIEW
                         11.17.2   SWOT ANALYSIS
                         11.17.3   REVENUE ANALYSIS
                         11.17.4   PRODUCT PORTFOLIO
                         11.17.5   RECENT DEVELOPEMENTS
                         11.17.5   DATA BRIDGE ANALYSIS

12. APPENDIX

13. ABOUT DATA BRIDGE MARKET RESEARCH

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List Of Figures

Please fill in the below form and our sales representatives will get back to you Shortly

Please fill in the below form and our sales representatives will get back to you Shortly

`